The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical mucositis and intestinal permeability abnormalities in metastatic colorectal cancer patients treated with irinotecan and 5-fluoruracil.
Markus Gifoni
No relevant relationships to disclose
Roberto Cesar Lima
No relevant relationships to disclose
Aldo Angelo Moreira Lima
No relevant relationships to disclose
Adriana Facanha
No relevant relationships to disclose
Rodrigo Barbosa Callado
No relevant relationships to disclose
Carolina Azevedo
No relevant relationships to disclose
Ronaldo De Albuquerque Ribeiro
No relevant relationships to disclose